The use of putative placebo in active control trials: two applications in a regulatory settingDURRLEMAN, Sylvain; CHAIKIN, Philip.Statistics in medicine. 2003, Vol 22, Num 6, pp 941-952, issn 0277-6715, 12 p.Conference Paper

Effects of supratherapeutic doses of ebastine and terfenadine on the QT intervalGILLEN, Michael S; MILLER, Barry; CHAIKIN, Philip et al.British journal of clinical pharmacology. 2001, Vol 52, Num 2, pp 201-204, issn 0306-5251Article

Clinical trial simulation of docetaxel in patients with cancer as a tool for dosage optimizationVEYRAT-FOLLET, Christine; BRUNO, René; OLIVARES, Robert et al.Clinical pharmacology and therapeutics. 2000, Vol 68, Num 6, pp 677-687, issn 0009-9236Article

Insourcing international clinical trials to affiliates : A business-driven and medically sound strategyCHAIKIN, Philip; DURRLEMAN, Sylvain; BERGER, Florence et al.Drug information journal. 2000, Vol 34, Num 4, pp 1293-1301, issn 0092-8615Article

α-1-Acid glycoprotein as an independent predictor for treatment effects and a prognostic factor of survival in patients with non-small cell lung cancer treated with docetaxelBRUNO, René; OLIVARES, Robert; BERILLE, Jocelyne et al.Clinical cancer research. 2003, Vol 9, Num 3, pp 1077-1082, issn 1078-0432, 6 p.Article

Pharmacokinetics/pharmacodynamics in drug development : An industrial perspectiveCHAIKIN, Philip; RHODES, Gerald R; BRUNO, Rene et al.Journal of clinical pharmacology. 2000, Vol 40, Num 12, pp 1428-1438, issn 0091-2700, 2Conference Paper

Adenosine A_2A Receptor Antagonist Istradefylline (KW-6002) Reduces Off' Time in Parkinson's Disease : A Double-Blind, Randomized, Multicenter Clinical Trial (6002-US-005)LEWITT, Peter A; GUTTMAN, M; TETRUD, James W et al.Annals of neurology. 2008, Vol 63, Num 3, pp 295-302, issn 0364-5134, 8 p.Article

In vitro and in vivo techniques used in drug development for evaluation of dose delivery of inhaled corticosteroidsRHODES, Gerald R; SHASHANK ROHATAGI; GILLEN, Michael S et al.Journal of clinical pharmacology. 2001, Vol 41, Num 1, pp 7-18, issn 0091-2700Article

Pharmacokinetic/pharmacodynamic modeling in drug research and developmentDERENDORF, Hartmut; LESKO, Lawrence J; CHAIKIN, Philip et al.Journal of clinical pharmacology. 2000, Vol 40, Num 12, pp 1399-1418, issn 0091-2700, 2Conference Paper

Defining the maximum tolerated dose : An updateCUTLER, Neal R; SRAMEK, John J; GREENBLATT, David J et al.Journal of clinical pharmacology. 2000, Vol 40, Num 11, pp 1183-1204, issn 0091-2700Article